Coexistence of Left Atrial Tumor and Lung Cancer-The Key Role of an Individualized Approach.
Maja HawryszkoGrzegorz LaskawskiHanna JankowskaKarolina DorniakAnna KochańskaLudmiła Daniłowicz-SzymanowiczEwa LewickaPublished in: Diagnostics (Basel, Switzerland) (2024)
During the diagnostic work-up in oncology, it is exceedingly rare to assume a concomitant presence of two cancers, a benign one and a malignant one, in a single patient. A 61-year-old man was admitted to the cardiology department for cardiac evaluation prior to planned radical treatment of non-small cell (NSCLC) left lung cancer (cT3N1M0). Echocardiography revealed a prominent, unpedunculated structure, measuring 17 × 14 mm, located in the left atrium (LA) near the fossa ovalis. The tumor was confirmed via cardiac magnetic resonance (CMR) imaging, which showed the radiological features of an atrial myxoma. The patient consulted with the Cardiac Surgery Department and was deemed ineligible for surgical treatment of a lesion with mucinous features; thus, no definitive histopathologic confirmation of the tumor present was possible. He was then successfully treated with radical radiochemotherapy and immunotherapy. During the 2-year follow-up, regular echocardiography and CMR were performed, which documented a stable LA tumor size.
Keyphrases
- left ventricular
- left atrial
- cardiac surgery
- magnetic resonance
- computed tomography
- atrial fibrillation
- small cell lung cancer
- pulmonary hypertension
- single cell
- mitral valve
- case report
- high resolution
- acute kidney injury
- catheter ablation
- squamous cell carcinoma
- tertiary care
- contrast enhanced
- heart failure
- pulmonary arterial hypertension
- radiation therapy
- pulmonary artery
- cell therapy
- palliative care
- mesenchymal stem cells
- mass spectrometry
- advanced non small cell lung cancer
- inferior vena cava
- photodynamic therapy
- combination therapy
- dual energy
- vena cava
- epidermal growth factor receptor
- left atrial appendage